|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
| The Diagnostics Outlook to 2005 |
|
|
|
|
€ 795,00 |
Editeur
: |
Business Insight |
Langue
: |
Anglais |
Date de publication : |
Février 1999 |
Taille du document : |
130 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Functional Proteomics and Emerging Bio-IT market
pages | Novembre 2002 |
The proteomic technique is not only limited to the study of one or few cellular products but also allows for qualitative and a quantitative measurement of several hundreds of proteins produced during |
250,00 €
|
| |
| |
03-052B: The DNA Purification Market: Keys to Success for Commercial Kit Suppliers
152 pages | Octobre 2003 |
This report is designed to help life science product managers understand customers in the DNA purification market and the factors that drive their purchasing behavior |
1 280,00 €
|
| |
| |
03-052A: Protein Purification Systems: Market Opportunities for Research Product Suppliers
163 pages | Octobre 2003 |
This report will help suppliers exploit opportunities to differentiate themselves from their competitors and develop more advanced protein purification tools |
960,00 €
|
| |
| |
Genomic Revolution: Trends & Opportunities
30 pages | Octobre 2002 |
Computational advancements in Genomic technology have brought a revolution in the field of application of Pharmaco-Therapy.
Companies are diversifying their business prospect from medical chemistry |
600,00 €
|
| |
| |
Carbohydrate Therapeutics
180 pages | Décembre 2000 |
Carbohydrates are the only class of biological molecule (there are four main classes: nucleic acids, proteins, lipids, and carbohydrates - commonly known as sugars), that can be found in direct associ |
1 400,00 €
|
| |
| |
Antisense Therapeutics IRCD
pages | Juin 2001 |
Antisense molecules are stretches of single-stranded nucleic acid that target and bind with a specific mRNA, interfering with and even preventing the translation or over-expression of the protein |
1 026,17 €
|
| |
| |
03-026: The Market for Tissue Microarrays
134 pages | Juillet 2003 |
This report provides vital information on end-users’ scientific objectives, instrumentation for production and analysis of TMAs, outsourcing practices and preferred TMA suppliers |
640,00 €
|
| |
| |
Integrating Genomics: The Next Generation
124 pages | Février 1999 |
Genomics research : Understand the key technologies including target identification (genome mapping, random sequencing and two-hybrid assay), target validation/assay development and current appli |
795,00 €
|
| |
| |
Pharmacogenomics
160 pages | Décembre 2000 |
The Human Genome Project and numerous corporate and academic human gene sequencing efforts have revealed, among others, that genes exist in the population in numerous mutated forms, some of which |
1 400,00 €
|
| |
| |
03-019: The Market for Microbial Genotyping Products: Research and Testing Applications
183 pages | Juin 2003 |
The report identifies the kits, reagents and instrumentation that are most commonly used for microbial identification and analysis in both the research and testing arenas |
800,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| The Diagnostics Outlook to 2005 |
|
|
Diagnostic market :
The current in vitro diagnostic (IVD) market is discussed, identifying how the
market can be segmented according to country, end user, clinical speciality
and disease area. In addition, current market drivers are highlighted.
Key players :
The leading players in the IVD market are discussed by segmenting them by company
type and by disease area focus.
Technology :
IVD technologies are outlined and benchmarked against one another.
Future :
The future direction of the IVD market is assessed, with respect to market drivers
and industry trends.
|
|
CHAPTER 1: THE CURRENT DIAGNOSTIC MARKET
CHAPTER 2: CURRENT AND FUTURE DIAGNOSTIC TECHNOLOGIES
CHAPTER 3: KEY PLAYERS IN THE DIAGNOSTIC MARKET
CHAPTER 4: FUTURE DIAGNOSTICS MARKET
CHAPTER 5: APPENDIX
|
|
|
PPLSEN
|
|
|
|
|
